Search results query ec: 2.7.11.24

Found 664 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Total Genus	Sequence Length	pdb	Title
116	349	8u8kA	Co-crystal structure of phosphorylated erk2 in complex with erk1/2 inhibitor #8
119	352	8u8jA	Co-crystal structure of phosphorylated erk2 in complex with erk1/2 inhibitor #16
98	344	8ygwA	The crystal structure of mapk11 from biortus
103	357	8x5mA	The crystal structure of jnk1 from biortus.
106	351	8x23A	The crystal structure of mapk13 from biortus.
103	350	7w5oA	Crystal structure of erk2 with an allosteric inhibitor
109	362	7opmA	Phosphorylated erk2 in complex with orf45
105	347	7e73A	Crystal structure of human erk2 mutant (y36h)
109	349	7e75A	Crystal structure of human erk2 mutant (g37c)
93	350	8acmAAA	Crystal structure of wt p38alpha
84	349	8acoAAA	Crystal structure of wt p38alpha
113	340	7pusAAA	Erk5 in complex with pyrrole carboxamide scaffold
114	355	7n8tA	Crystal structure of amp-bound human jnk2
111	356	8efjA	A structural study of selectivity mechanisms for jnk3 and p38 alpha with indazole scaffold probing compounds
95	356	8enjA	Design, synthesis, biological evaluation, and x-ray crystallography of diarylpyrazole derivatives possessing terminal arylsulfonamide moieties as anti-proliferative agents targeting c-jun n-terminal kinase (jnk)
107	356	7yl1A	Crystal structure of jnk3 in complex with a fragment molecule
112	355	8elcA	Human jnk2 bound to covalent inhibitor yl2056
109	350	7z6iAAA	Crystal structure of p38alpha c162s in complex with sb20358 and cas 2094667-81-7 (behind catalytic site; y35 in), p 21 21 21
103	349	7z9tAAA	Crystal structure of p38alpha c162s in complex with atpgs and cas 2094667-81-7 (in catalytic site, y35 out), p 1 21 1
106	349	7pvuA	Crystal structure of p38alpha c162s in complex with cas2094511-69-8, p 1 21 1
131	408	8h59A	A fungal map kinase in complex with an inhibitor
109	346	7ugbA	Crystal structure of rat erk2 complexed with docking peptide from isg20
112	351	7xc1A	Crystal structure of erk2 with an allosteric inhibitor 3
113	350	7x4uA	Crystal structure of erk2 with an allosteric inhibitor 2
111	355	7w5cA	Crystal structure of mitogen activated protein kinase 4 (mpk4) from arabidopsis thaliana
107	346	8aoeA	Specific covalent inhibitor(15) of erk2
112	346	8aoaA	Covalent and non-covalent inhibitor of erk2 (two sites)
105	346	8aogA	Non-specific covalent inhibitor(17) of erk2
114	346	8aoiA	Specific covalent inhibitor(19) of erk2
106	346	8ao6A	Electrophilic inhibitor (7) of erk2
110	342	8ao5A	Specific covalent inhibitor (6) of erk2
113	347	8aojA	Specific covalent inhibitor of erk2
107	346	8ao9A	Specific covalent inhibitor(10) of erk2
107	347	8ao4A	Specific covalent inhibitor (5) of erk2
108	346	8ao8A	Specific covalent inhibitor(9) of erk2
110	339	8aobA	Specific covalent inhibitor(12) of erk2
112	346	8aocA	Specific covalent inhibitor of erk2
109	347	8ao3A	Specific covalent inhibitor of erk2
107	346	8aohA	Specific covalent inhibitor(18) of erk2
114	346	8ao7A	Specific covalent inhibitor (8) of erk2
110	346	8aodA	Specific covalent inhibitor(14) of erk2
106	345	8ao2A	Specific covalent inhibitor (3) of erk2
106	346	8aofA	Specific covalent inhibitor(16) of erk2
66	349	8a8mA	Structure of the mapk p38alpha in complex with its activating map2k mkk6
102	356	7s1nA	N-aromatic-substituted indazole derivatives as brain penetrant and orally bioavailable jnk3 inhibitors
110	346	7nqqA	Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2
101	345	7nr9A	Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2
113	346	7nr8A	Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2
114	346	7nqwA	Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2
109	347	7nr5A	Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2